RSS-Feed abonnieren

DOI: 10.1055/a-2627-9243
Potential Role of Lymphovenous Bypass in Mitigating Alzheimer's Disease Dementia

Abstract
This case report explores the therapeutic potential of lymphovenous bypass (LVB) surgery performed at the neck in neurodegenerative diseases, specifically Alzheimer's disease (AD) dementia. The subject is a 58-year-old woman who was previously healthy but began experiencing unexplained memory decline and frequent disorientation in the past 7 years, leading to an AD diagnosis. Despite ongoing pharmaceutical therapy, her symptoms progressed to severe dementia accompanied by behavioral and psychological symptoms of dementia (BPSD). Her Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores were both 0/30, and 18F-AV-45 PET/CT revealed abnormal brain amyloid load. For salvage therapy, she underwent LVBs on her neck bilaterally. Postoperatively, she got better MMSE and MoCA scores with dramatic improvement in communication and activity. 18F-AV-45 PET/CT scans 4 months after surgery indicated a reduction in abnormal brain amyloid deposits. This case report highlights the potential effectiveness of LVB surgery in reducing brain amyloid load and attenuating cognitive impairment and BPSD. Further research with animal experiments and clinical trials is necessary to confirm these findings.
Keywords
Alzheimer's disease - dementia - behavioral and psychological symptoms - brain lymphatics - lymphovenous bypassAuthors' Contributions
Q.X. initiated the idea, conducted the surgery and participated in collecting data. S.-C.C. analyzed data, drafted the manuscript and as a corresponding author. C.J.P. and J.K. contributed conceptual discussion. J.P.H. supervised the project and helped to revise the manuscript. The authors read and approved the final manuscript.
Ethical Approval
This data collection, including chart review and photo/video recording, was approved by the Institutional Review Board (IRB #000005).
Patient Consent
Informed consent was obtained from all patients prior to inclusion in the study.
Publikationsverlauf
Eingereicht: 01. Januar 2025
Angenommen: 29. Mai 2025
Accepted Manuscript online:
13. Juni 2025
Artikel online veröffentlicht:
23. Juli 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol 2018; 17 (11) 1016-1024
- 2 Ma Q, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun 2017; 8 (01) 1434
- 3 Aspelund A, Antila S, Proulx ST. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 2015; 212 (07) 991-999
- 4 Da Mesquita S, Louveau A, Vaccari A. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature 2018; 560 (7717): 185-191
- 5 Chao S, Kuan C, Huang C. et al. Association between cervical lymph node dissection and dementia: a retrospective analysis. J Plast Reconstr Aesthet Surg 2024; 99: 584-591
- 6 Nauen DW, Troncoso JC. Amyloid-beta is present in human lymph nodes and greatly enriched in those of the cervical region. Alzheimers Dement 2022; 18 (02) 205-210
- 7 Xie Q, Louveau A, Pandey S, Zeng W, Chen WF. Rewiring the brain: The next frontier in supermicrosurgery. Plast Reconstr Surg 2024; 153 (02) 494e-495e
- 8 Li X, Zhang C, Fang Y. et al. Promising outcomes 5 weeks after a surgical cervical shunting procedure to unclog cerebral lymphatic systems in a patient with Alzheimer's disease. Gen Psychiatr 2024; 37 (03) e101641
- 9 Navitsky M, Joshi AD, Kennedy I. et al. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the centiloid scale. Alzheimers Dement 2018; 14 (12) 1565-1571
- 10 Iaccarino L, Burnham SC, Tunali I. et al. A practical overview of the use of amyloid-PET centiloid values in clinical trials and research. Neuroimage Clin 2025; 46: 103765
- 11 Klunk WE, Koeppe RA, Price JC. et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 2015; 11 (01) 1-15.e1, 4
- 12 Yağmurlu K, Sokolowski JD, Çırak M. et al. Anatomical features of the deep cervical lymphatic system and intrajugular lymphatic vessels in humans. Brain Sci 2020; 10 (12) 953
- 13 Kohan EJ, Wirth GA. Anatomy of the neck. Clin Plast Surg 2014; 41 (01) 1-6
- 14 Chen WF, Yamamoto T, Fisher M, Liao J, Carr J. The “octopus” lymphaticovenular anastomosis: Evolving beyond the standard supermicrosurgical technique. J Reconstr Microsurg 2015; 31 (06) 450-457
- 15 Pak CS, Suh HP, Kwon JG, Cho MJ, Hong JP. Lymph node to vein anastomosis (LNVA) for lower extremity lymphedema. J Plast Reconstr Aesthet Surg 2021; 74 (09) 2059-2067
- 16 Briggs R, Kennelly SP, O'Neill D. Drug treatments in Alzheimer's disease. Clin Med (Lond) 2016; 16 (03) 247-253
- 17 Duarte ESR, Jacinto AF. Behavioral and psychological symptoms of dementia in the long-term care setting: assessment of aged adults and intervention for caregivers. Dement Neuropsychol 2023; 17: e20230018
- 18 Bélanger-Dibblee M, Pham Thi-Desmarteau S, Jacques MC, Tremblay H, Roy-Desruisseaux J. The experiences, needs, and solutions of caregivers of patients with behavioral and psychological symptoms of dementia living in residential and long-term care centers. Qual Health Res 2023; 33 (10) 871-883
- 19 Camus V, Payoux P, Barré L. et al. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging 2012; 39 (04) 621-631
- 20 Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's disease. Alzheimers Res Ther 2019; 11 (01) 34
- 21 Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement 2015; 11 (01) 58-69
- 22 Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer's disease: Clinical Practice in 2021. J Prev Alzheimers Dis 2021; 8 (03) 371-386
- 23 Ashton NJ, Brum WS, Di Molfetta G. et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol 2024; 81 (03) 255-263
- 24 Bohr T, Hjorth PG, Holst SC. et al. The glymphatic system: Current understanding and modeling. iScience 2022; 25 (09) 104987